ID   PACN2_HUMAN             Reviewed;         486 AA.
AC   Q9UNF0; O95921; Q96HV9; Q9H0D3; Q9NPN1; Q9Y4V2;
DT   13-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-2002, sequence version 2.
DT   22-JUL-2015, entry version 134.
DE   RecName: Full=Protein kinase C and casein kinase substrate in neurons protein 2;
DE   AltName: Full=Syndapin-2;
DE   AltName: Full=Syndapin-II;
GN   Name=PACSIN2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Retina;
RX   PubMed=10431838; DOI=10.1016/S0014-5793(99)00830-3;
RA   Ritter B., Modregger J., Paulsson M., Plomann M.;
RT   "PACSIN 2, a novel member of the PACSIN family of cytoplasmic adapter
RT   proteins.";
RL   FEBS Lett. 454:356-362(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 335-486 (ISOFORM 2).
RG   The European IMAGE consortium;
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=11082044;
RA   Modregger J., Ritter B., Witter B., Paulsson M., Plomann M.;
RT   "All three PACSIN isoforms bind to endocytic proteins and inhibit
RT   endocytosis.";
RL   J. Cell Sci. 113:4511-4521(2000).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=11179684; DOI=10.1016/S0378-1119(00)00531-X;
RA   Sumoy L., Pluvinet R., Andreu N., Estivill X., Escarceller M.;
RT   "PACSIN 3 is a novel SH3 domain cytoplasmic adapter protein of the
RT   pacsin-syndapin-FAP52 gene family.";
RL   Gene 262:199-205(2001).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   FUNCTION, DOMAIN, AND SUBCELLULAR LOCATION.
RX   PubMed=21610094; DOI=10.1242/jcs.086264;
RA   Senju Y., Itoh Y., Takano K., Hamada S., Suetsugu S.;
RT   "Essential role of PACSIN2/syndapin-II in caveolae membrane
RT   sculpting.";
RL   J. Cell Sci. 124:2032-2040(2011).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH RAC1.
RX   PubMed=21693584; DOI=10.1242/jcs.080630;
RA   de Kreuk B.J., Nethe M., Fernandez-Borja M., Anthony E.C.,
RA   Hensbergen P.J., Deelder A.M., Plomann M., Hordijk P.L.;
RT   "The F-BAR domain protein PACSIN2 associates with Rac1 and regulates
RT   cell spreading and migration.";
RL   J. Cell Sci. 124:2375-2388(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23129763; DOI=10.1074/jbc.M112.391078;
RA   de Kreuk B.J., Anthony E.C., Geerts D., Hordijk P.L.;
RT   "The F-BAR protein PACSIN2 regulates epidermal growth factor receptor
RT   internalization.";
RL   J. Biol. Chem. 287:43438-43453(2012).
RN   [16]
RP   FUNCTION, AND DOMAIN.
RX   PubMed=23236520; DOI=10.1371/journal.pone.0051628;
RA   Goh S.L., Wang Q., Byrnes L.J., Sondermann H.;
RT   "Versatile membrane deformation potential of activated pacsin.";
RL   PLoS ONE 7:E51628-E51628(2012).
RN   [17]
RP   FUNCTION IN MEMBRANE TUBULATION, LIPID-BINDING, SUBCELLULAR LOCATION,
RP   AND INTERACTION WITH EHD1; EHD3 AND MICALL1.
RX   PubMed=23596323; DOI=10.1091/mbc.E13-01-0026;
RA   Giridharan S.S., Cai B., Vitale N., Naslavsky N., Caplan S.;
RT   "Cooperation of MICAL-L1, syndapin2, and phosphatidic acid in tubular
RT   recycling endosome biogenesis.";
RL   Mol. Biol. Cell 24:1776-1790(2013).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.78 ANGSTROMS), AND DOMAIN.
RX   PubMed=19549836; DOI=10.1073/pnas.0902974106;
RA   Wang Q., Navarro M.V., Peng G., Molinelli E., Goh S.L., Judson B.L.,
RA   Rajashankar K.R., Sondermann H.;
RT   "Molecular mechanism of membrane constriction and tubulation mediated
RT   by the F-BAR protein Pacsin/Syndapin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:12700-12705(2009).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1-305, AND DOMAIN.
RX   PubMed=20188097; DOI=10.1016/j.febslet.2010.02.058;
RA   Shimada A., Takano K., Shirouzu M., Hanawa-Suetsugu K., Terada T.,
RA   Toyooka K., Umehara T., Yamamoto M., Yokoyama S., Suetsugu S.;
RT   "Mapping of the basic amino-acid residues responsible for tubulation
RT   and cellular protrusion by the EFC/F-BAR domain of pacsin2/Syndapin
RT   II.";
RL   FEBS Lett. 584:1111-1118(2010).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 16-304.
RX   PubMed=22573331; DOI=10.1074/jbc.M112.358960;
RA   Bai X., Meng G., Luo M., Zheng X.;
RT   "Rigidity of wedge loop in PACSIN 3 protein is a key factor in
RT   dictating diameters of tubules.";
RL   J. Biol. Chem. 287:22387-22396(2012).
CC   -!- FUNCTION: Lipid-binding protein that is able to promote the
CC       tubulation of the phosphatidic acid-containing membranes it
CC       preferentially binds. Plays a role in intracellular vesicle-
CC       mediated transport. Involved in the endocytosis of cell-surface
CC       receptors like the EGF receptor, contributing to its
CC       internalization in the absence of EGF stimulus. May also play a
CC       role in the formation of caveolae at the cell membrane. Recruits
CC       DNM2 to caveolae, and thereby plays a role in caveola-mediated
CC       endocytosis. {ECO:0000269|PubMed:21610094,
CC       ECO:0000269|PubMed:21693584, ECO:0000269|PubMed:23129763,
CC       ECO:0000269|PubMed:23236520, ECO:0000269|PubMed:23596323}.
CC   -!- SUBUNIT: Homodimer. May form heterooligomers with other PACSINs.
CC       Interacts (via NPF motifs) with EHD1 (via EH domain). Interacts
CC       with EHD3. Interacts (via the SH3 domain) with MICALL1. Interacts
CC       with RAC1. Interacts (via SH3 domain) with DNM1, SYN1, SYNJ1 and
CC       WASL. Interacts with CAV1. Interacts with TRPV4.
CC       {ECO:0000269|PubMed:21693584, ECO:0000269|PubMed:23596323}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-742503, EBI-742503;
CC       P50570:DNM2; NbExp=4; IntAct=EBI-742503, EBI-346547;
CC       P48023:FASLG; NbExp=4; IntAct=EBI-742503, EBI-495538;
CC       A4D127:MEOX2; NbExp=3; IntAct=EBI-742503, EBI-10172134;
CC       Q9BY11:PACSIN1; NbExp=5; IntAct=EBI-742503, EBI-721769;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cytoplasm,
CC       cytoskeleton {ECO:0000250}. Cytoplasmic vesicle membrane;
CC       Peripheral membrane protein; Cytoplasmic side. Early endosome.
CC       Recycling endosome membrane. Cell projection, ruffle membrane;
CC       Peripheral membrane protein; Cytoplasmic side. Cell membrane;
CC       Peripheral membrane protein; Cytoplasmic side. Cell projection
CC       {ECO:0000250}. Membrane, caveola. Note=Detected at the neck of
CC       flask-shaped caveolae. Localization to tubular recycling endosomes
CC       probably requires interaction with MICALL1 and EHD1.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UNF0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UNF0-2; Sequence=VSP_004517;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:11082044, ECO:0000269|PubMed:11179684}.
CC   -!- DOMAIN: The F-BAR domain forms a coiled coil and mediates
CC       membrane-binding and membrane tubulation. In the autoinhibited
CC       conformation, interaction with the SH3 domain inhibits membrane
CC       tubulation mediated by the F-BAR domain.
CC       {ECO:0000269|PubMed:19549836, ECO:0000269|PubMed:20188097,
CC       ECO:0000269|PubMed:21610094, ECO:0000269|PubMed:23236520}.
CC   -!- PTM: Phosphorylated by casein kinase 2 (CK2) and protein kinase C
CC       (PKC). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the PACSIN family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 F-BAR domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU01077}.
CC   -!- SIMILARITY: Contains 1 SH3 domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00192}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF128536; AAD41781.1; -; mRNA.
DR   EMBL; AL136845; CAB66779.1; -; mRNA.
DR   EMBL; CR456536; CAG30422.1; -; mRNA.
DR   EMBL; AL022476; CAI20163.1; -; Genomic_DNA.
DR   EMBL; AL049758; CAI20163.1; JOINED; Genomic_DNA.
DR   EMBL; AL049758; CAI20948.1; -; Genomic_DNA.
DR   EMBL; AL022476; CAI20948.1; JOINED; Genomic_DNA.
DR   EMBL; BC008037; AAH08037.1; -; mRNA.
DR   EMBL; AL389984; CAB97538.1; -; mRNA.
DR   CCDS; CCDS43023.1; -. [Q9UNF0-1]
DR   CCDS; CCDS54536.1; -. [Q9UNF0-2]
DR   RefSeq; NP_001171899.1; NM_001184970.1. [Q9UNF0-1]
DR   RefSeq; NP_001171900.1; NM_001184971.1. [Q9UNF0-2]
DR   RefSeq; NP_009160.2; NM_007229.3. [Q9UNF0-1]
DR   RefSeq; XP_005261376.1; XM_005261319.3. [Q9UNF0-2]
DR   UniGene; Hs.162877; -.
DR   PDB; 3ABH; X-ray; 2.00 A; A/B=1-305.
DR   PDB; 3ACO; X-ray; 2.70 A; A/B=1-343.
DR   PDB; 3HAJ; X-ray; 2.78 A; A/B=1-486.
DR   PDB; 3Q0K; X-ray; 2.60 A; A/B/C/D=16-304.
DR   PDBsum; 3ABH; -.
DR   PDBsum; 3ACO; -.
DR   PDBsum; 3HAJ; -.
DR   PDBsum; 3Q0K; -.
DR   ProteinModelPortal; Q9UNF0; -.
DR   SMR; Q9UNF0; 16-303, 429-484.
DR   BioGrid; 116413; 41.
DR   IntAct; Q9UNF0; 9.
DR   MINT; MINT-5005738; -.
DR   STRING; 9606.ENSP00000263246; -.
DR   PhosphoSite; Q9UNF0; -.
DR   BioMuta; PACSIN2; -.
DR   DMDM; 22256968; -.
DR   MaxQB; Q9UNF0; -.
DR   PaxDb; Q9UNF0; -.
DR   PRIDE; Q9UNF0; -.
DR   DNASU; 11252; -.
DR   Ensembl; ENST00000263246; ENSP00000263246; ENSG00000100266.
DR   Ensembl; ENST00000402229; ENSP00000385040; ENSG00000100266.
DR   Ensembl; ENST00000403744; ENSP00000385372; ENSG00000100266.
DR   GeneID; 11252; -.
DR   KEGG; hsa:11252; -.
DR   UCSC; uc003bdg.4; human. [Q9UNF0-1]
DR   CTD; 11252; -.
DR   GeneCards; GC22M043243; -.
DR   HGNC; HGNC:8571; PACSIN2.
DR   HPA; HPA049854; -.
DR   MIM; 604960; gene.
DR   neXtProt; NX_Q9UNF0; -.
DR   PharmGKB; PA32897; -.
DR   eggNOG; NOG283356; -.
DR   GeneTree; ENSGT00510000046376; -.
DR   HOGENOM; HOG000007245; -.
DR   HOVERGEN; HBG053486; -.
DR   InParanoid; Q9UNF0; -.
DR   OMA; HHAACKE; -.
DR   PhylomeDB; Q9UNF0; -.
DR   TreeFam; TF313677; -.
DR   ChiTaRS; PACSIN2; human.
DR   EvolutionaryTrace; Q9UNF0; -.
DR   GeneWiki; PACSIN2; -.
DR   GenomeRNAi; 11252; -.
DR   NextBio; 42818; -.
DR   PRO; PR:Q9UNF0; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; Q9UNF0; -.
DR   ExpressionAtlas; Q9UNF0; baseline and differential.
DR   Genevisible; Q9UNF0; HS.
DR   GO; GO:0005901; C:caveola; IDA:UniProtKB.
DR   GO; GO:0005911; C:cell-cell junction; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0019898; C:extrinsic component of membrane; ISS:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0031988; C:membrane-bounded vesicle; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0055038; C:recycling endosome membrane; IDA:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0070300; F:phosphatidic acid binding; IDA:UniProtKB.
DR   GO; GO:0005215; F:transporter activity; TAS:ProtInc.
DR   GO; GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc.
DR   GO; GO:0070836; P:caveola assembly; IMP:UniProtKB.
DR   GO; GO:0072584; P:caveolin-mediated endocytosis; IMP:UniProtKB.
DR   GO; GO:0048858; P:cell projection morphogenesis; ISS:UniProtKB.
DR   GO; GO:0097320; P:membrane tubulation; IDA:UniProtKB.
DR   GO; GO:0045806; P:negative regulation of endocytosis; IEA:Ensembl.
DR   GO; GO:0036010; P:protein localization to endosome; IMP:UniProtKB.
DR   GO; GO:0030100; P:regulation of endocytosis; IBA:GO_Central.
DR   InterPro; IPR031160; F_BAR.
DR   InterPro; IPR001060; FCH_dom.
DR   InterPro; IPR028521; PACSIN2.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR10959:SF2; PTHR10959:SF2; 1.
DR   Pfam; PF00611; FCH; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS51741; F_BAR; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell membrane;
KW   Cell projection; Coiled coil; Complete proteome; Cytoplasm;
KW   Cytoplasmic vesicle; Cytoskeleton; Endocytosis; Endosome;
KW   Lipid-binding; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; SH3 domain.
FT   CHAIN         1    486       Protein kinase C and casein kinase
FT                                substrate in neurons protein 2.
FT                                /FTId=PRO_0000161795.
FT   DOMAIN       11    282       F-BAR. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01077}.
FT   DOMAIN      426    486       SH3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00192}.
FT   COILED       25    274
FT   MOTIF       362    364       NPF1.
FT   MOTIF       405    407       NPF2.
FT   MOTIF       417    419       NPF3.
FT   MOD_RES      53     53       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WVE8}.
FT   VAR_SEQ     344    384       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11230166,
FT                                ECO:0000303|Ref.6}.
FT                                /FTId=VSP_004517.
FT   VARIANT     175    175       N -> S (in dbSNP:rs35383004).
FT                                /FTId=VAR_053555.
FT   VARIANT     294    294       M -> I (in dbSNP:rs2746984).
FT                                /FTId=VAR_013711.
FT   VARIANT     324    324       V -> F (in dbSNP:rs1062913).
FT                                /FTId=VAR_013712.
FT   CONFLICT    182    182       L -> F (in Ref. 1; AAD41781).
FT                                {ECO:0000305}.
FT   CONFLICT    256    256       D -> N (in Ref. 1; AAD41781).
FT                                {ECO:0000305}.
FT   CONFLICT    309    309       N -> I (in Ref. 1; AAD41781).
FT                                {ECO:0000305}.
FT   CONFLICT    336    336       S -> F (in Ref. 1; AAD41781).
FT                                {ECO:0000305}.
FT   CONFLICT    378    380       DDT -> EDI (in Ref. 1; AAD41781).
FT                                {ECO:0000305}.
FT   TURN         21     24       {ECO:0000244|PDB:3ABH}.
FT   HELIX        25     72       {ECO:0000244|PDB:3ABH}.
FT   HELIX        77    106       {ECO:0000244|PDB:3ABH}.
FT   HELIX       108    119       {ECO:0000244|PDB:3ABH}.
FT   STRAND      126    128       {ECO:0000244|PDB:3ABH}.
FT   HELIX       129    169       {ECO:0000244|PDB:3ABH}.
FT   HELIX       172    177       {ECO:0000244|PDB:3ABH}.
FT   HELIX       185    188       {ECO:0000244|PDB:3ABH}.
FT   HELIX       189    191       {ECO:0000244|PDB:3ABH}.
FT   TURN        192    195       {ECO:0000244|PDB:3ABH}.
FT   HELIX       197    255       {ECO:0000244|PDB:3ABH}.
FT   HELIX       257    259       {ECO:0000244|PDB:3ABH}.
FT   HELIX       263    275       {ECO:0000244|PDB:3ABH}.
FT   HELIX       279    290       {ECO:0000244|PDB:3ABH}.
SQ   SEQUENCE   486 AA;  55739 MW;  821DBEF65DAD1AA8 CRC64;
     MSVTYDDSVG VEVSSDSFWE VGNYKRTVKR IDDGHRLCSD LMNCLHERAR IEKAYAQQLT
     EWARRWRQLV EKGPQYGTVE KAWMAFMSEA ERVSELHLEV KASLMNDDFE KIKNWQKEAF
     HKQMMGGFKE TKEAEDGFRK AQKPWAKKLK EVEAAKKAHH AACKEEKLAI SREANSKADP
     SLNPEQLKKL QDKIEKCKQD VLKTKEKYEK SLKELDQGTP QYMENMEQVF EQCQQFEEKR
     LRFFREVLLE VQKHLDLSNV AGYKAIYHDL EQSIRAADAV EDLRWFRANH GPGMAMNWPQ
     FEEWSADLNR TLSRREKKKA TDGVTLTGIN QTGDQSLPSK PSSTLNVPSN PAQSAQSQSS
     YNPFEDEDDT GSTVSEKDDT KAKNVSSYEK TQSYPTDWSD DESNNPFSST DANGDSNPFD
     DDATSGTEVR VRALYDYEGQ EHDELSFKAG DELTKMEDED EQGWCKGRLD NGQVGLYPAN
     YVEAIQ
//
